drugset
drugset / Trial / NCT03896815

Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

NCT03896815 ↗

Expanded access No longer available Incyte Corporation

Summary

Expanded access use of INCB054329 to treat a single patient with metastatic renal cell carcinoma.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB054329 Unknown — —

Indications

No indication recorded.